Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jun;59(6):510-516.
doi: 10.1007/s00117-019-0524-7.

[Contrast agent-free breast MRI : Advantages and potential disadvantages]

[Article in German]
Affiliations
Review

[Contrast agent-free breast MRI : Advantages and potential disadvantages]

[Article in German]
P A T Baltzer et al. Radiologe. 2019 Jun.

Abstract

Background: Contrast-enhanced breast magnetic resonance imaging (MRI) is the most sensitive method for detection of breast cancer. The further spread of breast MRI is limited by the complicated examination procedure and the need for intravenously administered contrast media.

Objectives: Can diffusion-weighted imaging (DWI) replace contrast-enhanced sequences to achieve an unenhanced breast MRI examination?

Materials and methods: Narrative review and meta-analytic assessment of previously published studies.

Results: DWI can visualize breast lesions and distinguish benign from malignant findings. It is thus a valid alternative to contrast-enhanced sequences. As an additional technique, the use of DWI can reduce the numbers of unnecessary breast biopsies. The lack of robustness leading to variable sensitivity that is currently lower than that of contrast-enhanced breast MRI is a disadvantage of DWI.

Conclusions: Presently, DWI can be recommended as an integral part of clinical breast MRI protocols. The application as a stand-alone technique within unenhanced protocols is still under evaluation.

Keywords: Breast cancer; Diffusion-weighted imaging; Magnetic resonance imaging; Screening; Sensitivity.

PubMed Disclaimer

References

    1. Radiol Clin North Am. 1992 Jan;30(1):1-19 - PubMed
    1. Radiology. 2007 Sep;244(3):672-91 - PubMed
    1. Ann Intern Med. 2008 May 6;148(9):671-9 - PubMed
    1. J Clin Oncol. 2008 Jul 1;26(19):3248-58 - PubMed
    1. Eur Radiol. 2009 Jul;19(7):1612-20 - PubMed

LinkOut - more resources